Endothelial-cell-specific molecule-1 (ECSM-1 or endocan) is a recently identified proteoglycan released from the vascular endothelium and associated with increased tissue expression, endothelial activation (inflammation), and neovascularization (tumor progression) [10]. Here, ESM1 is linked to neoplasm.